In KEAP1, cancer-related missense mutations in the KREP domain were reported to be pathogenic through diverse molecular effects such as reduced binding of Nrf2 (mainly mutations at Nrf2 binding sites in the shallow pocket) and decreased protein stability or abundance (mutations outside the shallow pocket)49–51. The gene discussed is KEAP1; the disease is cancer.